Related Experiment Videos
Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages
1Division of Clinical Biochemistry and Human Metabolism, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Journal of Lipid Research
|April 6, 2001
Summary
Alpha-tocopherol (AT) reduces scavenger receptor expression and cholesterol buildup in macrophages. This finding supports AT's role in preventing atherosclerosis.
Area of Science:
- Cardiovascular Research
- Cell Biology
- Nutritional Science
Background:
- Cholesterol-laden macrophages are central to atherosclerosis development.
- The scavenger receptor CD36 binds oxidized low-density lipoprotein (OxLDL) and is upregulated in atherosclerotic lesions.
Purpose of the Study:
- To investigate the impact of alpha-tocopherol (AT) on CD36 expression and cholesteryl ester accumulation in human macrophages.
- To assess the antiatherogenic potential of AT.
Main Methods:
- Human monocytes were cultured into macrophages and enriched with varying doses of AT.
- Macrophages were incubated with oxidized LDL (OxLDL) or acetylated LDL (AcLDL).
- CD36 expression was measured by flow cytometry; scavenger receptor class A (SR-A) activity and cholesteryl ester accumulation were quantified.
Main Results:
- AT (≥50 μM) significantly reduced OxLDL- and AcLDL-induced CD36 expression.
- AT treatment decreased DiI-AcLDL and DiI-OxLDL uptake.
- Cholesteryl ester accumulation was significantly inhibited by AT (77% for AcLDL, 42% for OxLDL).
Conclusions:
- Alpha-tocopherol decreases both CD36 and SR-A expression in human macrophages.
- AT significantly reduces cholesteryl ester accumulation, indicating a potential role in preventing atherosclerosis.